TEVA R&D to Revenue
Teva Pharmaceutical Industries Limited American Depositary Shares · R&D to Revenue
TEVA R&D to Revenue
Latest reported5.87%period ending
TEVA FY R&D/Revenue (0.00% → 5.87%)
Latest values, visible window
High-resolution chart · PNG
TEVA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5.8701% | |
| 6.3769% | |
| 6.0145% | |
| 5.6147% | |
| 6.89% | |
| 10.769% | |
| 5.9809% | |
| 6.4336% | |
| 8.2555% | |
| 9.6379% | |
| 7.76% | |
| 7.3402% | |
| 7.0247% | |
| 6.6742% | |
| 5.9797% | |
| 5.7875% | |
| 5.7702% | |
| 7.0907% | |
| 6.1756% | |
| 5.8873% | |
| 7.0261% | |
| 7.0516% | |
| 6.5163% | |
| 6.5513% | |
| 5.1639% | |
| 5.9762% | |
| 6.3819% | |
| 6.1027% | |
| 5.8376% | |
| 6.5842% | |
| 4.7327% | |
| 6.2277% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |